Skip to search.
 TSX Up 1.00% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Geron Corporation (GERN)

-NasdaqGS
1.97 0.11(5.91%) Apr 16, 4:00PM EDT
Add to Portfolio
Prev Close:1.86
Open:1.88
Bid:1.92 x 100
Ask:1.98 x 2000
1y Target Est:2.00
Beta:2.46
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:1.85 - 1.98
52wk Range:1.01 - 7.79
Volume:3,054,524
Avg Vol (3m):6,543,490
Market Cap:309.09M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Must Read

Comparison

Symbol% ChgMkt Cap
GERNUp 5.91%309.09M
BMY81.04B
GSK126.53B
NVS204.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):227.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Mar-14) :-0.06
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-1.43

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback